{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:17:06Z","timestamp":1790295426924,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To comprehensively assess the global burden of syphilis and related risk factors over 1990\u20132021, forecast future disease trends, and understand the impact of syphilis on global health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Global Burden of Disease Study 2021 (GBD 2021) data were used for age-, sex-, and region-stratified analysis of the numbers and age-standardized rates (per 100,000 population) of syphilis incidence, prevalence, deaths, and disability-adjusted life years (DALYs). Next, a differential analysis of syphilis risk factors was performed. Finally, trends for years after 2021 were predicted using Bayesian age\u2013period\u2013cohort (BAPC) prediction models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2021, the total number of syphilis prevalence globally was 70,541,482.80 (95% uncertainty interval: 54,910,897.66\u201388,207,651.97), with the highest numbers noted in Central Sub-Saharan Africa [4,622.60 (95% uncertainty interval: 3,591.97\u20135,753.45)]. Over 1990\u20132021, the global age-standardized prevalence and incidence rates increased, whereas the age-standardized death and DALY rates decreased. Among all groups, infants aged &amp;lt;5\u2009years demonstrated the highest age-standardized DALY rates. Moreover, the lower the sociodemographic index (SDI), the higher was the age-standardized rate. The primary factor contributing to syphilis disease burden was identified to be unsafe sex. BAPC analysis revealed an overall increase in age-standardized prevalence rate in the &amp;lt;5-year age group over 1990\u20132035, and the highest age-standardized prevalence rate occurred in the 25\u201334-year age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Between 1990 and 2021, syphilis occurrence and prevalence increased consistently. Projections indicated a continual increase in syphilis incidence in children aged &amp;lt;5\u2009years, and age-standardized prevalence rates were the highest in adults aged 25\u201334\u2009years. Our results regarding the epidemiological trends of syphilis and its variations across regions, age groups, and sexes may aid policymakers in addressing the global impact of the disease effectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2024.1448841","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:41:57Z","timestamp":1723682517000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Global, regional, and national burden of syphilis, 1990\u20132021 and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021"],"prefix":"10.3389","volume":"11","author":[{"given":"Wenxia","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e00102022","DOI":"10.1590\/0037-8682-0010-2022","article-title":"Burden of syphilis in Brazil and federated units, 1990-2016: estimates from the global burden of Disease study 2019","volume":"55","author":"Bezerra","year":"2022","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0068622","DOI":"10.1128\/spectrum.00686-22","article-title":"British Columbia's experience after implementation of the Treponema pallidum reverse algorithm and PCR detection, 2015 to 2020","volume":"10","author":"Morshed","year":"2022","journal-title":"Microbiol Spectr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e01092-16","DOI":"10.1128\/AAC.01092-16","article-title":"Efficacy of doxycycline in the treatment of syphilis","volume":"61","author":"Dai","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","first-page":"113","article-title":"Syphilis - an update","volume":"40","author":"Stock","year":"2017","journal-title":"Med Monatsschr Pharm"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.eimc.2018.12.009","article-title":"Syphilis","volume":"37","author":"Arando Lasagabaster","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"103281","DOI":"10.1016\/j.ebiom.2021.103281","article-title":"Efficacy of linezolid on Treponema pallidum, the syphilis agent: a preclinical study","volume":"65","author":"Haynes","year":"2021","journal-title":"EBioMedicine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1001545","DOI":"10.1371\/journal.pmed.1001545","article-title":"Antenatal syphilis screening using point-of-care testing in sub-Saharan African countries: a cost-effectiveness analysis","volume":"10","author":"Kuznik","year":"2013","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"17073","DOI":"10.1038\/nrdp.2017.73","article-title":"Syphilis","volume":"3","author":"Peeling","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.idc.2023.02.006","article-title":"Syphilis: a modern resurgence","volume":"37","author":"Ramchandani","year":"2023","journal-title":"Infect Dis Clin N Am"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e1110","DOI":"10.1016\/S2214-109X(21)00221-7","article-title":"Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000-20","volume":"9","author":"Tsuboi","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of Disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of Disease study 2021","volume":"403","author":"Diseases","year":"2024","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.3346\/jkms.2019.34.e75","article-title":"Trends and patterns of burden of disease and Injuries in Korea using disability-adjusted life years","volume":"34","author":"Kim","year":"2019","journal-title":"J Korean Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the global burden of Disease study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"key":"ref15","first-page":"4","article-title":"Brief history of syphilis","volume":"7","author":"Tampa","year":"2014","journal-title":"J Med Life"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1126170","DOI":"10.3389\/fimmu.2023.1126170","article-title":"Syphilis vaccine: challenges, controversies and opportunities","volume":"14","author":"Avila-Nieto","year":"2023","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.annepidem.2019.01.013","article-title":"Geographic correlates of primary and secondary syphilis among men who have sex with men in the United States","volume":"32","author":"Leichliter","year":"2019","journal-title":"Ann Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1586\/14787210.2015.990384","article-title":"Syphilis in the United States: on the rise?","volume":"13","author":"Peterman","year":"2015","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e0159309","DOI":"10.1371\/journal.pone.0159309","article-title":"Syphilis trends among men who have sex with men in the United States and Western Europe: a systematic review of trend studies published between 2004 and 2015","volume":"11","author":"Abara","year":"2016","journal-title":"PLoS One"},{"key":"ref20","first-page":"402","article-title":"Primary and secondary syphilis--United States, 2005-2013","volume":"63","author":"Patton","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ad.2019.03.014","article-title":"The epidemiological and clinical characteristics of the epidemic of syphilis in Barcelona","volume":"110","author":"Arando","year":"2019","journal-title":"Actas Dermosifiliogr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e33009","DOI":"10.7759\/cureus.33009","article-title":"Congenital syphilis epidemiology, prevention, and management in the United States: a 2022 update","volume":"14","author":"Fang","year":"2022","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.3390\/ijerph191710513","article-title":"Clinical protocols and treatment guidelines for the management of maternal and congenital syphilis in Brazil and Portugal: analysis and comparisons: a narrative review","volume":"19","author":"de Brito Pinto","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.clp.2021.03.005","article-title":"Syphilis in neonates and infants","volume":"48","author":"Medoro","year":"2021","journal-title":"Clin Perinatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ajog.2022.07.041","article-title":"Syphilis in pregnancy: an ongoing public health threat","volume":"227","author":"Eppes","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1016\/S1473-3099(23)00314-6","article-title":"Resurgence of congenital syphilis: new strategies against an old foe","volume":"24","author":"Moseley","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e50702","DOI":"10.2196\/50702","article-title":"Epidemiology of syphilis in pregnancy and congenital syphilis in Brazil and the risk or associated factors: protocol for a systematic review","volume":"13","author":"Pinheiro","year":"2024","journal-title":"JMIR Res Protoc"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/QCO.0000000000000875","article-title":"New trends in congenital syphilis: epidemiology, testing in pregnancy, and management","volume":"35","author":"Thean","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e230033","DOI":"10.1590\/1980-549720230033","article-title":"Syphilis detection rate trend in aged people: Brazil, 2011-2019","volume":"26","author":"Barros","year":"2023","journal-title":"Rev Bras Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1900311","DOI":"10.2807\/1560-7917.ES.2019.24.45.1900311","article-title":"A proposal for changes to the European Union syphilis surveillance case definition using evidence from evaluations in Ireland","volume":"24","author":"Petty-Saphon","year":"2019","journal-title":"Euro Surveill"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/jcm13061603","article-title":"Atypical manifestations of syphilis: a 10-year retrospective study","volume":"13","author":"Ciccarese","year":"2024","journal-title":"J Clin Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.adengl.2016.02.002","article-title":"Atypical cutaneous manifestations in syphilis","volume":"107","author":"Ivars Lleo","year":"2016","journal-title":"Actas Dermosifiliogr"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1448841\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:42:01Z","timestamp":1723682521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1448841\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":32,"alternative-id":["10.3389\/fmed.2024.1448841"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1448841","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"1448841"}}